Prevalence and risk factors for diabetes and diabetic retinopathy: Results from the Nigeria national blindness and visual impairment survey

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Kyari, Fatima ^a,b   Tafida, Abubakar ^c   Sivasubramaniam, Selvaraj ^d   Murthy, Gudlavalleti V S ^a,e   Peto, Tunde ^f   Gilbert, Clare E ^a   Abdull, Mohammed M ^g   Abiose, Adenike ^h   Entekume, Gabriel ⁱ   Ezelum, Christian ^j   Faal, Hannah B ^k   Imam, Abdullahi ^l   Lee, Pak Sang ^m   Rabiu, Mansur M ⁿ   Bankole, Olufunmilayo O ^o  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF ABUJA   (Nigeria)

^c Ministry of Health   (Nigeria)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^f MOORFIELDS EYE HOSPITAL   (United Kingdom)

^g ABUBAKAR TAFAWA BALEWA UNIVERSITY   (Nigeria)

^h Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS   (Nigeria)

ⁱ Vision Health Services   (Nigeria)

^j Ministry of Health   (Nigeria)

^k Africa Vision Research Institute (AVRI)   (South Africa)

^l Ministry of Health   (Nigeria)

^m UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁿ National Eye Centre   (Nigeria)

^o Isolo General Hospital   (Nigeria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BLINDNESS; CLUSTER ANALYSIS; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMAN; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLINDNESS; CLUSTER ANALYSIS; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; RISK FACTORS;

EID: 84924331022     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-1299     Document Type: Article

References (64)

1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE: Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014, 103:137-149.
2. World Health Organization: Prevention of blindness from diabetes mellitus: report of a WHO consultation in Geneva, Switzerland, 9-11 November 2005. Geneva: World Health Organization; 2006.
3. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O'Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM, Varma R, Wang JJ, Wang N, et al.: Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012, 35:556-564.
4. Mohamed Q, Gillies MC, Wong TY: Management of diabetic retinopathy: a systematic review. JAMA 2007, 298:902-916.
5. World Health Organization: Diabetes Surveillance. Source: The National Expert Committee on NCD. Non-communicable diseases in Nigeria. Final report of a national survey. Federal Ministry of Health and Social Services, 1997. In WHO Global Infobase Version: 1292beta IBRef 100935a1. 2005:25-26.nigeria-ndm-countryprofile.pdf. www.afro.who.int/en/downloads/doc-download/2528-nigeria.html. Last accessed 23 December 2014.
6. Nyenwe EA, Odia OJ, Ihekwaba AE, Ojule A, Babatunde S: Type 2 diabetes in adult Nigerians: a study of its prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Res Clin Pract 2003, 62:177-185.
7. Owoaje EE, Rotimi CN, Kaufman JS, Tracy J, Cooper RS: Prevalence of adult diabetes in Ibadan, Nigeria. East Afr Med J 1997, 74:299-302.
8. Bakari AG, Onyemelukwe GC, Sani BG, Aliyu IS, Hassan SS, Aliyu TM: Prevalence of diabetes in suburban northern Nigeria: results of a public screening survey. Diab Int 1999, 9:59-60.
9. Onyemelukwe GC: The national expert committee on non-communicable diseases in Nigeria: report of a national survey of non-communicable diseases (south-west zone). In Federal Ministry of Health. 2003. http://www.profgconyemelukwe.com/publications/national-reports/ (Nigeria NCD survey) Last accessed 23 December 2014.
10. Puepet FH, Ohwovoriole AE: Prevalence of risk factors for diabetes mellitus in a non-diabetic population in Jos, Nigeria. Niger J Med 2008, 17:71-74.
11. Dahiru T, Jibo A, Hassan AA, Mande AT: Prevalence of diabetes in a semiurban community in Northern Nigeria. Niger J Med 2008, 17:414-416.
12. Ekpenyong CE, Udokang NE, Akpan EE, Samson TK: Double burden, non-communicable diseases and risk factors evaluation in sub-Saharan Africa: The Nigerian experience. Eur J Sustainable Dev 2012, 1:249-270.
13. Amoah AG, Owusu SK, Adjei S: Diabetes in Ghana: a community based prevalence study in Greater Accra. Diabetes Res Clin Pract 2002, 56:197-205.
14. Murthy GV, Fox S, Sivasubramaniam S, Gilbert CE, Mahdi AM, Imam AU, Entekume G: Prevalence and risk factors for hypertension and association with ethnicity in Nigeria: results from a national survey. Cardiovasc J Afr 2013, 24:1-7.
15. United Nations: United Nations. 2013. http://data.un.org/CountryProfile.aspx?crName=NIGERIA. Last accessed 23 December 2014.
16. Kyari F, Gudlavalleti MV, Sivsubramaniam S, Gilbert CE, Abdull MM, Entekume G, Foster A: Prevalence of blindness and visual impairment in Nigeria: the National Blindness and Visual Impairment Study. Invest Ophthalmol Vis Sci 2009, 50:2033-2039.
17. Abdull MM, Sivasubramaniam S, Murthy GV, Gilbert C, Abubakar T, Ezelum C, Rabiu MM: Causes of blindness and visual impairment in Nigeria: the Nigeria national blindness and visual impairment survey. Invest Ophthalmol Vis Sci 2009, 50:4114-4120.
18. Dineen B, Gilbert CE, Rabiu M, Kyari F, Mahdi AM, Abubakar T, Ezelum CC, Gabriel E, Elhassan E, Abiose A, Faal H, Jiya JY, Ozemela CP, Lee PS, Gudlavalleti MV: The Nigerian national blindness and visual impairment survey: Rationale, objectives and detailed methodology. BMC Ophthalmol 2008, 8:17.
19. Mehra V, Minassian DC: A rapid method of grading cataract in epidemiological studies and eye surveys. Br J Ophthalmol 1988, 72:801-803.
20. Rosser DA, Laidlaw DA, Murdoch IE: The development of a "reduced logMAR" visual acuity chart for use in routine clinical practice. Br J Ophthalmol 2001, 85:432-436.
21. Bourne RR, Rosser DA, Sukudom P, Dineen B, Laidlaw DA, Johnson GJ, Murdoch IE: Evaluating a new logMAR chart designed to improve visual acuity assessment in population-based surveys. Eye (Lond) 2003, 17:754-758.
22. Thylefors B, Chylack LT Jr, Konyama K, Sasaki K, Sperduto R, Taylor HR, West S: A simplified cataract grading system. Ophthalmic Epidemiol 2002, 9:83-95.
23. Gavin III JR, Alberti KGMM, Davidson MB, DeFronzo RA, Drash A, Gabbe SG, Genuth S, Harris MI, Kahn R, Keen H, Knowler WC, Lebovitz H, Maclaren NK, Palmer JP, Raskin P, Rizza RA, and Stern MP, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl 1):S5-20.
24. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991, 98:786-806.
25. World Health Organization: Definition of Blindness. 2010. http://www.who.int/blindness/Change%20the%20Definition%20of%20Blindness.pdf. Last accessed 23 December 2014.
26. World Health Organization: Coding Instructions for the WHO/PBL Eye Examination Record (version III). PBL/881 Geneva: WHO; 1988.
27. World Health Organization: Clinical guidelines for the management of hypertension. Cairo: EMRO Technical Publications Series; 29 WHO Regional Office for the Eastern Mediterranean; 2005.
28. World Health Organization: Global database on Body Mass Index. BMI classification. 2010. http://apps.who.int/bmi/index.jsp?introPage=intro-3.html. Last accessed 23 December 2014.
29. Ogunkolo OF, Amballi AA: Prevalence of Diabetes Mellitus in Newly Admitted Undergraduates of Olabisi Onabanjo University, Nigeria. NigMed Pract 2005, 47:26-28.
30. Erasmus RT, Ebonyi E, Fakeye C: Prevalence of diabetes mellitus in a rural Nigerian population. Nig Med Pract 1988, 15:128-138.
31. Varma R, Torres M, Pena F, Klein R, Azen SP: Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology 2004, 111:1298-1306.
32. Al Ghamdi AH, Rabiu M, Hajar S, Yorston D, Kuper H, Polack S: Rapid assessment of avoidable blindness and diabetic retinopathy in Taif, Saudi Arabia. Br J Ophthalmol 2012, 96:1168-1172.
33. Polack S, Yorston D, Lopez-Ramos A, Lepe-Orta S, Baia RM, Alves L, Grau-Alvidrez C, Gomez-Bastar P, Kuper H: Rapid assessment of avoidable blindness and diabetic retinopathy in Chiapas, Mexico. Ophthalmology 2012, 119:1033-1040.
34. Krishnaiah S, Das T, Nirmalan PK, Shamanna BR, Nutheti R, Rao GN, Thomas R: Risk factors for diabetic retinopathy: Findings from The Andhra Pradesh Eye Disease Study. Clin Ophthalmol 2007, 1:475-482.
35. Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, Lim SC, Tai ES, Mitchell P: Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 2008, 115:1869-1875.
36. Raman R, Rani PK, Reddi Rachepalle S, Gnanamoorthy P, Uthra S, Kumaramanickavel G, Sharma T: Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology 2009, 116:311-318.
37. Wang FH, Liang YB, Zhang F, Wang JJ, Wei WB, Tao QS, Sun LP, Friedman DS, Wang NL, Wong TY: Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology 2009, 116:461-467.
38. Zheng Y, Lamoureux EL, Lavanya R, Wu R, Ikram MK, Wang JJ, Mitchell P, Cheung N, Aung T, Saw SM, Wong TY: Prevalence and risk factors of diabetic retinopathy in migrant Indians in an urbanized society in Asia: the Singapore Indian eye study. Ophthalmology 2012, 119:2119-2124.
39. Jee D, Lee WK, Kang S: Prevalence and risk factors for diabetic retinopathy: the Korea national health and nutrition examination survey 2008-2011. Invest Ophthalmol Vis Sci 2013, 54:6827-6833.
40. Saquib N, Khanam MA, Saquib J, Anand S, Chertow GM, Barry M, Ahmed T, Cullen MR: High prevalence of type 2 diabetes among the urban middle class in Bangladesh. BMC Public Health 2013, 13:1032.
41. Mbanya JC, Ngogang J, Salah JN, Minkoulou E, Balkau B: Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in Cameroon. Diabetologia 1997, 40:824-829.
42. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF: Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab 2001, 27:628-634.
43. Bakari AG, Onyemelukwe GC, Sani BG, Aliyu IS, Hassan SS, Aliyu TM: Relationship between random blood sugar and body mass index in an African population. Int J Diab Metab 2006, 14:144-145.
44. Dowse GK, Humphrey AR, Collins VR, Plehwe W, Gareeboo H, Fareed D, Hemraj F, Taylor HR, Tuomilehto J, Alberti KG, Zimmet PZ: Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol 1998, 147:448-457.
45. Wang J, Zhang RY, Chen RP, Sun J, Yang R, Ke XY, Chen H, Cai DH: Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population. BMC Public Health 2013, 13:633.
46. Schellini SA, Carvalho GM, Rendeiro FS, Padovani CR, Hirai FE: Prevalence of diabetes and diabetic retinopathy in a brazilian population. Ophthalmic Epidemiol 2014, 21:33-38.
47. Azevedo M, Alla S: Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia. Int J Diabetes Dev Ctries 2008, 28:101-108.
48. Mbanya JC, Sobngwi E: Diabetes microvascular and macrovascular disease in Africa. J Cardiovasc Risk 2003, 10:97-102.
49. Bek T, Lund-Andersen H, Hansen AB, Johnsen KB, Sandbaek A, Lauritzen T: The prevalence of diabetic retinopathy in patients with screen-detected type 2 diabetes in Denmark: the ADDITION study. Acta Ophthalmol 2009, 87:270-274.
50. Osuntokun BO: Diabetic retinopathy in Nigerians. A study of 758 patients. Br J Ophthalmol 1969, 53:652-663.
51. Abiose A: Pattern of retinal diseases in Lagos. Ann Ophthalmol 1979, 11:1067-1072.
52. Erasmus RT, Alanamu RA, Bojuwoye B, Oluboyo P, Arije A: Diabetic retinopathy in Nigerians: relation to duration of diabetes, type of treatment and degree of control. East Afr Med J 1989, 66:248-254.
53. Nwosu SNN: Diabetic Retinopathy in Nnewi, Nigeria. Nig J Ophthalmol Vol 8, No1 (August 2000): pp 7-10
54. 2000, 8:7-10.
55. Magulike N, Chuka-Okosa CM, Oli JM: Diabetic Eye Disease in Enugu South-Eastern Nigeria - A Preliminary Report. Nig J Ophthalmol 2003, 11:30-33.
56. Ashaye A, Arije A, Kuti M, Olusanya B, Ayeni E, Fasanmade A, Akinlade K, Obajimi M, Adeleye J: Retinopathy among type 2 diabetic patients seen at a tertiary hospital in Nigeria: a preliminary report. Clin Ophthalmol 2008, 2:103-108.
57. Onakpoya OH, Olateju SO, Ajayi IA: Retinal diseases in a tertiary hospital: the need for establishment of a vitreo-retinal care unit. J Natl Med Assoc 2008, 100:1286-1289.
58. Agaba EI: Characteristics of type 2 diabetics presenting with end stage renal disease at the Jos University Teaching Hospital, Nigeria. West Afr J Med 2004, 23:142-145.
59. Omolase CO, Adekanle O, Owoeye JF, Omolase BO: Diabetic retinopathy in a Nigerian community. Singapore Med J 2010, 51:56-59.
60. Lawan A, Mohammed TB: Pattern of diabetic retinopathy in Kano, Nigeria. Ann Afr Med 2012, 11:75-79.
61. World Health Organization: Tobacco Use. Source: The National Expert Committee on NCD. Non-communicable diseases in Nigeria. Final report of a national survey. Federal Ministry of Health and Social Services, 1997. In WHO Global Infobase Version: 1292beta IBRef 100935a1. 2005:1-4. www.afro.who.int/en/downloads/doc-download/2528-nigeria.html. Last accessed 23 December 2014.
62. Economic Impact of Diabetes: International Diabetes Federation. IDF Atlas, 6th edn. Background papers: Brussels, Belgium; 2014. http://www.idf.org/sites/default/files/Economic%20impact%20of%20Diabetes-0.pdf. Last accessed 23 December 2014.
63. Burgess PI, Msukwa G, Beare NA: Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic. BMC Med 2013, 11:157.
64. Hassan AO, Okonkwo ON: The challenges of vitreoretinal surgery in Nigeria. Annals of Ibadan Postgraduate Med 2004, 1:9-15.